SCHEMBL3283469

SCHEMBL3283469

[CH2]CCC1CC(=O)OC1=O

nearest known ligand 0.40

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4168233 0.86 TSHR (0.44) ALDH1A1TSHR
SCHEMBL15095421 0.82 ALDH1A1 (0.46) ALDH1A1TSHR
SCHEMBL12000454 0.82 ALDH1A1 (0.46) ALDH1A1TSHR
SCHEMBL20251162 0.80 ALDH1A1 (0.49) ALDH1A1TSHR
SCHEMBL20251160 0.80 ALDH1A1 (0.49) ALDH1A1TSHR
SCHEMBL16522363 0.80 ALDH1A1 (0.49) ALDH1A1TSHR
SCHEMBL20251191 0.80 ALDH1A1 (0.49) ALDH1A1TSHR
SCHEMBL16522360 0.80 ALDH1A1 (0.49) ALDH1A1TSHR
SCHEMBL29109668 0.78 ALDH1A1 (0.51) ALDH1A1TSHR
SCHEMBL9061452 0.78 ALDH1A1 (0.40) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7834120-B2 Monofunctional monomer having cage oligosiloxane structure and method of making SHIN-ETSU CHEMICAL CO., LTD. (JP) 2010-11-16 US claimed
US-8956807-B2 Method for forming resist pattern, and composition for forming resist underlayer film JSR CORPORATION (JP) 2015-02-17 US disclosed
US-20130101942-A1 METHOD FOR FORMING RESIST PATTERN, AND COMPOSITION FOR FORMING RESIST UNDERLAYER FILM JSR CORPORATION (JP) 2013-04-25 US disclosed
US-7902392-B2 Method for the production of organosilicon compounds comprising carboxy radicals WACKER CHEMIE AG (DE) 2011-03-08 US disclosed
US-7834120-B2 Monofunctional monomer having cage oligosiloxane structure and method of making SHIN-ETSU CHEMICAL CO., LTD. (JP) 2010-11-16 US disclosed
US-7700196-B2 Method for producing carbonyl group-containing organosilicon compounds WACKER CHEMIE AG (DE) 2010-04-20 US disclosed
US-20100016519-A1 COLORED ORGANOPOLYSILOXANES DYSTAR COLOURS DEUTSCHLAND GMBH (DE) 2010-01-21 US disclosed
US-20090221842-A1 METHOD FOR THE PRODUCTION OF ORGANOSILICON COMPOUNDS COMPRISING CARBOXY RADICALS WACKER CHEMIE AG (DE) 2009-09-03 US disclosed
US-20090209743-A1 COLOURED ORGANOPOLYSILOXANES DYSTAR COLOURS DEUTSCHLAND GMBH (DE) 2009-08-20 US disclosed
EP-1865016-B1 Organosilicon compounds comprising cyclodextrin radicals WACKER CHEMIE AG (DE) 2008-11-26 EP disclosed
EP-1685183-A2 METHOD FOR PRODUCING CARBONYL REST-CONTAINING ORGANOSILICON COMPOUNDS Wacker Chemie AG (DE) 2006-08-02 EP disclosed
EP-1548049-B1 Method for preparation of organosilicon compounds WACKER CHEMIE AG (DE) 2006-07-26 EP disclosed
US-7074950-B2 Process for preparing organosilicon compounds WACKER-CHEMIE GMBH (DE) 2006-07-11 US disclosed
EP-1645560-A1 Monofunctional monomer having cage oligosiloxane structure and method of making Shin-Etsu Chemical Co., Ltd. (JP) 2006-04-12 EP disclosed
US-20060074213-A1 Monofunctional monomer having cage oligosiloxane structure and method of making SHIN-ETSU CHEMICAL CO., LTD. (JP) 2006-04-06 US disclosed
US-20060009592-A1 Organosilicon compounds comprising cyclodextrin radicals WACKER-CHEMIE GMBH (DE) 2006-01-12 US disclosed
WO-2005103060-A1 METHOD FOR THE PRODUCTION OF ORGANOSILICON COMPOUNDS COMPRISING CARBOXY RADICALS WACKER CHEMIE AG (DE) 2005-11-03 WO disclosed
EP-1548049-A1 Method for preparation of organosilicon compounds Wacker-Chemie GmbH (DE) 2005-06-29 EP disclosed
US-20050137412-A1 Process for preparing organosilicon compounds WACKER-CHEMIE GMBH (DE) 2005-06-23 US disclosed
WO-2005049697-A2 METHOD FOR PRODUCING CARBONYL REST-CONTAINING ORGANOSILICON COMPOUNDS WACKER CHEMIE AG (DE) 2005-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209743-A1 COLOURED ORGANOPOLYSILOXANES MSR1, ARSA, HBS1L ALDH1A1 335/4885TSHR 1694/4885
US-20050137412-A1 Process for preparing organosilicon compounds OSTC, SCO2, ELOC ALDH1A1 3428/4885TSHR 4849/4885
US-20090221842-A1 METHOD FOR THE PRODUCTION OF ORGANOSILICON COMPOUNDS COMPRISING CARBOXY RADICALS HAO2, CBR3, SOD3 ALDH1A1 1595/4885TSHR 4591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.